Commercial Marijuana Research Gets Green Light
Announcement from: Eric Nash


VANCOUVER ISLAND, BC, July 6 /CNW/ - PhytoCan Pharmaceuticals is developing the first certified organic cannabis based medicines. The BC company is producing products in adherence to the new federal government national organic standards.

Health Canada has conditionally approved PhytoCan Pharmaceuticals Inc. to conduct scientific research into cannabis based medicines using Island Harvest(TM) certified organic cannabis.

"In the past 3 years, Island Harvest has developed the cannabis strains we require." states Operations Manager Wendy Little.

Health Canada recently announced "Health Canada recognizes the need for research into marihuana to determine the safety and efficacy of its use. The Government of Canada will continue to support this research."

Vancouver Coastal Health Authority Chief Medical Officer Dr. John Blatherwick comments, "PhytoCan's application to do research into these areas is highly supportable."

PhytoCan president Eric Nash states "We are pleased to announce, with two years of consultations with Health Canada, the approval of our research and product development."

PhytoCan is using exclusive patented technology to produce standardized organic cannabis medicines. After second phase of research, a product will be ready for clinical trials.

For further information: please contact: Eric Nash: (250) 748-8614,
Email: info@phytocan.ca, Web: www.phytocan.ca

© 2005 H.U.M.A.N.: Hemp Users Medical Access Network - Toronto Medical Marijuana